CN107714798B - A kind of traditional Chinese medicine composition for treating chloasma and preparation method thereof - Google Patents
A kind of traditional Chinese medicine composition for treating chloasma and preparation method thereof Download PDFInfo
- Publication number
- CN107714798B CN107714798B CN201711087678.8A CN201711087678A CN107714798B CN 107714798 B CN107714798 B CN 107714798B CN 201711087678 A CN201711087678 A CN 201711087678A CN 107714798 B CN107714798 B CN 107714798B
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- medicine composition
- raw materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 42
- 206010008570 Chloasma Diseases 0.000 title claims abstract description 37
- 208000003351 Melanosis Diseases 0.000 title claims abstract description 37
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 239000002994 raw material Substances 0.000 claims abstract description 35
- 241000132012 Atractylodes Species 0.000 claims abstract description 20
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 19
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 19
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 18
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 17
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 17
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 16
- 235000006679 Mentha X verticillata Nutrition 0.000 claims abstract description 16
- 235000002899 Mentha suaveolens Nutrition 0.000 claims abstract description 16
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims abstract description 16
- 241000220317 Rosa Species 0.000 claims abstract description 15
- 238000001035 drying Methods 0.000 claims abstract description 10
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 8
- 244000197580 Poria cocos Species 0.000 claims abstract description 8
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 8
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 7
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 3
- 241000628997 Flos Species 0.000 claims abstract 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract 2
- 235000011477 liquorice Nutrition 0.000 claims abstract 2
- 241000736199 Paeonia Species 0.000 claims description 16
- 244000236658 Paeonia lactiflora Species 0.000 claims description 16
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 10
- 238000005516 engineering process Methods 0.000 claims description 8
- 239000004375 Dextrin Substances 0.000 claims description 6
- 229920001353 Dextrin Polymers 0.000 claims description 6
- 235000019425 dextrin Nutrition 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 241000382455 Angelica sinensis Species 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 abstract description 9
- 230000001815 facial effect Effects 0.000 abstract description 5
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 5
- 239000002552 dosage form Substances 0.000 abstract description 4
- 230000037075 skin appearance Effects 0.000 abstract description 3
- 244000170916 Paeonia officinalis Species 0.000 abstract 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 230000000857 drug effect Effects 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 28
- 230000000694 effects Effects 0.000 description 25
- 239000008280 blood Substances 0.000 description 23
- 210000004369 blood Anatomy 0.000 description 23
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 20
- 238000011282 treatment Methods 0.000 description 19
- 241000202726 Bupleurum Species 0.000 description 18
- 241001164374 Calyx Species 0.000 description 16
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 16
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 16
- 235000001287 Guettarda speciosa Nutrition 0.000 description 16
- 229940010454 licorice Drugs 0.000 description 16
- 210000000952 spleen Anatomy 0.000 description 15
- 230000017531 blood circulation Effects 0.000 description 13
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- 244000061520 Angelica archangelica Species 0.000 description 10
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 10
- 241000202807 Glycyrrhiza Species 0.000 description 10
- 235000017803 cinnamon Nutrition 0.000 description 10
- 210000002216 heart Anatomy 0.000 description 10
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 10
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 241000125175 Angelica Species 0.000 description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000005906 menstruation Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 208000012641 Pigmentation disease Diseases 0.000 description 5
- 238000007689 inspection Methods 0.000 description 5
- 230000002175 menstrual effect Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 230000001914 calming effect Effects 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 230000019612 pigmentation Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 206010006313 Breast tenderness Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 208000009849 Female Genital Neoplasms Diseases 0.000 description 3
- 206010022998 Irritability Diseases 0.000 description 3
- 240000005809 Prunus persica Species 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 102000003425 Tyrosinase Human genes 0.000 description 3
- 108060008724 Tyrosinase Proteins 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 208000031513 cyst Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- 241001106477 Paeoniaceae Species 0.000 description 1
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000109329 Rosa xanthina Species 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000035614 depigmentation Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 229940127234 oral contraceptive Drugs 0.000 description 1
- 239000003539 oral contraceptive agent Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 235000021018 plums Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
技术领域technical field
本发明涉及中药技术领域,且特别涉及一种用于治疗黄褐斑的中药组合物及其制备方法。The invention relates to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for treating chloasma and a preparation method thereof.
背景技术Background technique
黄褐斑也称肝斑,是一种好发于女性的面部色素沉着性疾病,临床发病率高,损害为黄褐或深褐色斑片,常对称分布于颧颊部,也可累及眶周、前额、上唇和鼻部,边缘一般较明显。色斑深浅与季节,日晒,内分泌因素有关。精神紧张,熬夜,劳累可加重皮损。黄褐斑临床发病率较高,病因尚不清楚,西医认为其发病与妊娠、长期口服避孕药、月经紊乱、妇科疾病等有关。本病虽然一般不影响健康,但持续存在或增多、加深的面部色斑,会影响人的美观,从而降低人的生活质量。Chloasma, also known as liver spot, is a kind of facial pigmentation disease that occurs mainly in women. It has a high clinical incidence and is characterized by yellow or dark brown patches. , forehead, upper lip and nose, the edges are generally more pronounced. The depth of pigmentation is related to seasons, sun exposure, and endocrine factors. Mental stress, staying up late, and fatigue can aggravate skin lesions. The clinical incidence of chloasma is relatively high, and the etiology is still unclear. Western medicine believes that its incidence is related to pregnancy, long-term oral contraceptives, menstrual disorders, and gynecological diseases. Although this disease generally does not affect health, persistent or increased or deepened facial pigmentation will affect people's appearance and thus reduce people's quality of life.
目前西医治疗黄褐斑的方法多采用防晒、外用脱色剂、面膜、激光,或口服维生素C、E,但仅能短期改善斑色,易于复发加重,而且不能解决其他的伴随症状。At present, western medicine treatment methods for chloasma mostly use sunscreen, topical depigmentation agent, facial mask, laser, or oral vitamin C and E, but they can only improve the melasma in the short term, are prone to recurrence and aggravation, and cannot solve other accompanying symptoms.
发明内容SUMMARY OF THE INVENTION
本发明的目的在于提供一种用于治疗黄褐斑的中药组合物,使用安全,可淡化或消退面部色斑,改善皮肤外观,提高生活质量。The purpose of the present invention is to provide a traditional Chinese medicine composition for treating chloasma, which is safe to use, can lighten or subside facial pigmentation, improve skin appearance, and improve quality of life.
本发明的另一目的在于提供一种用于治疗黄褐斑的中药组合物的制备方法,该制备方法简单易行,可操作性强,保持了药效的同时,易于工业化生产,通过剂型的改变,便于患者随身携带服用。Another object of the present invention is to provide a preparation method of a traditional Chinese medicine composition for treating chloasma. The preparation method is simple and easy to operate, has strong operability, and is easy to industrialize production while maintaining the efficacy. Change, easy for patients to take with them.
本发明解决其技术问题是采用以下技术方案来实现的。The present invention solves its technical problems by adopting the following technical solutions.
本发明提出一种用于治疗黄褐斑的中药组合物,按重量份数计,主要由以下原料制成:桂枝5~15份,茯苓10~20份,桃仁5~15份,赤芍10~20份,白芍10~20份,丹皮10~20份,当归15~25份,柴胡5~15份,白术10~20份,甘草2~8份,薄荷5~15份,玫瑰花15~25份,红花10~20份,绿萼梅10~20份。The invention provides a traditional Chinese medicine composition for treating chloasma, which is mainly prepared from the following raw materials in parts by weight: 5-15 parts of cinnamon sticks, 10-20 parts of Poria cocos, 5-15 parts of peach kernels, Radix Paeoniae Alba 10-20 servings, 10-20 servings of white peony root, 10-20 servings of paeonol, 15-25 servings of angelica, 5-15 servings of Bupleurum, 10-20 servings of Atractylodes, 2-8 servings of licorice, 5-15 servings of mint, 15 to 25 roses, 10 to 20 safflowers, and 10 to 20 green calyx plums.
本发明提出一种用于治疗黄褐斑的中药组合物的制备方法,包括:将原料干燥、粉碎,与辅料混合。The present invention provides a preparation method of a traditional Chinese medicine composition for treating chloasma, which comprises: drying and pulverizing raw materials, and mixing with auxiliary materials.
本发明实施例的一种用于治疗黄褐斑的中药组合物及其制备方法的有益效果是:The beneficial effects of a traditional Chinese medicine composition for treating chloasma and a preparation method thereof according to the embodiment of the present invention are:
本发明参照现代药物研究,结合临床经验形成科学的组方,桂枝温通经脉,助阳化气;茯苓健脾宁心;桃仁活血祛瘀;赤芍散瘀;白芍平抑肝阳;丹皮活血化瘀;当归补血活血;柴胡疏肝解郁;白术健脾益气;甘草补脾益气;薄荷疏肝行气;玫瑰花清热解毒;红花活血散瘀;绿萼梅平肝和胃,调畅气机。The invention refers to modern drug research and combines clinical experience to form a scientific formula. Guizhi warms the meridians, helps yang to transform qi; Poria invigorates the spleen and calms the heart; Peach kernel promotes blood circulation and removes blood stasis; Skin activating blood and removing blood stasis; Angelica tonifying blood and promoting blood circulation; Chaihu soothing liver and relieving stagnation; Bai Zhu invigorating spleen and nourishing qi; Licorice tonifying spleen and nourishing qi; Peppermint soothing liver and promoting qi; Rose flower clearing heat and detoxifying; Stomach, adjust Qi machine.
该组方具有“疏肝健脾、解郁淡斑、活血化瘀”的作用,能够调节机体免疫力,改善血液循环,清除自由基,提高抗氧化性,从而起到抑制络氨酸酶活性,减少黑色素的形成,淡化或消退黄褐斑,改善皮肤外观,提高生活质量。同时该组方对于烦躁抑郁,眩晕耳鸣,经前乳房胀痛,腹胀痛,月经量少等症状以及妇科肿瘤或囊肿均具有一定治疗作用。该组方选用天然中草药为原料,安全性能高,无毒副作用。The formula has the functions of "soothing the liver and spleen, relieving depression and light spots, promoting blood circulation and removing blood stasis", which can regulate the body's immunity, improve blood circulation, scavenge free radicals, improve antioxidant properties, thereby inhibiting the activity of tyrosinase , reduces the formation of melanin, lightens or fades melasma, improves skin appearance and improves quality of life. At the same time, the prescription has a certain therapeutic effect on irritability and depression, dizziness and tinnitus, breast tenderness before menstruation, abdominal distention pain, light menstrual flow and other symptoms, as well as gynecological tumors or cysts. The prescription adopts natural Chinese herbal medicine as raw material, and has high safety performance and no toxic and side effects.
具体实施方式Detailed ways
为使本发明实施例的目的、技术方案和优点更加清楚,下面将对本发明实施例中的技术方案进行清楚、完整地描述。实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者,均为可以通过市售购买获得的常规产品。In order to make the objectives, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be described clearly and completely below. If the specific conditions are not indicated in the examples, it is carried out according to the conventional conditions or the conditions suggested by the manufacturer. The reagents or instruments used without the manufacturer's indication are conventional products that can be purchased from the market.
下面对本发明实施例的一种用于治疗黄褐斑的中药组合物及其制备方法进行具体说明。A traditional Chinese medicine composition for treating chloasma and a preparation method thereof according to an embodiment of the present invention will be specifically described below.
本发明实施例提供的一种用于治疗黄褐斑的中药组合物,按重量份数计,主要由以下原料制成:A kind of traditional Chinese medicine composition for the treatment of chloasma provided by the embodiment of the present invention, by weight, is mainly made from the following raw materials:
桂枝5~15份,茯苓10~20份,桃仁5~15份,赤芍10~20份,白芍10~20份,丹皮10~20份,当归15~25份,柴胡5~15份,白术10~20份,甘草2~8份,薄荷5~15份,玫瑰花15~25份,红花10~20份,绿萼梅10~20份。较优的,桂枝可以为6份、7份,茯苓可以为11份,桃仁可以为6份、7份,赤芍可以为11份,白芍可以为11份,丹皮可以为11份,当归可以为16份、17份,柴胡可以为6份、7份,白术可以为11份,丹皮可以为11份,当归可以为16份、17份,柴胡可以为6份、7份,白术可以为11份,甘草可以为3份、4份、6份、7份,薄荷可以为6份、7份,玫瑰花可以为16份、17份,红花可以为11份,绿萼梅可以为11份。5-15 parts of cinnamon sticks, 10-20 parts of Poria, 5-15 parts of peach kernel, 10-20 parts of red peony root, 10-20 parts of white peony root, 10-20 parts of paeonol, 15-25 parts of angelica root, 5-20 parts of bupleurum 15 parts, Atractylodes 10-20 parts, Licorice 2-8 parts, Mint 5-15 parts, Rose 15-25 parts, Safflower 10-20 parts, Green calyx plum 10-20 parts. Preferably, cassia twig can be 6 parts, 7 parts, Poria can be 11 parts, peach kernel can be 6 parts, 7 parts, red peony can be 11 parts, white peony can be 11 parts, paeony can be 11 parts, Angelica can be 16, 17, Bupleurum can be 6, 7, Atractylodes can be 11, Danpi can be 11, Angelica can be 16, 17, Bupleurum can be 6, 7 , Atractylodes can be 11 parts, licorice can be 3 parts, 4 parts, 6 parts, 7 parts, mint can be 6 parts, 7 parts, rose can be 16 parts, 17 parts, safflower can be 11 parts, green calyx can be 11 parts Plum can be 11 servings.
进一步地,在本发明较优的实施例中,按重量份数计,原料包括:桂枝8~12份,茯苓12~18份,桃仁8~12份,赤芍12~18份,白芍12~18份,丹皮12~18份,当归18~22份,柴胡8~12份,白术12~18份,甘草2~8份,薄荷8~12份,玫瑰花18~22份,红花12~18份,绿萼梅12~18份。较优的,桂枝可以为9份、11份,茯苓可以为13份、14份、16份、17份,桃仁可以为9份、11份,赤芍可以为13份、14份、16份,白芍可以为14份、16份、17份,丹皮可以为13份、17份,当归可以为19份、21份,柴胡可以为9份、11份,白术可以为13份、17份,薄荷可以为9份、11份,红花可以为14份、16份,绿萼梅可以为13份、17份。Further, in a preferred embodiment of the present invention, in parts by weight, the raw materials include: 8-12 parts of cassia twig, 12-18 parts of Poria, 8-12 parts of peach kernel, 12-18 parts of red peony root, white peony root 12-18 parts, 12-18 parts of Danpi, 18-22 parts of Angelica, 8-12 parts of Bupleurum, 12-18 parts of Atractylodes, 2-8 parts of Licorice, 8-12 parts of Peppermint, 18-22 parts of Rose, 12 to 18 copies of safflower, 12 to 18 copies of green calyx plum. Preferably, cassia twig can be 9 parts, 11 parts, Poria can be 13 parts, 14 parts, 16 parts, 17 parts, peach kernel can be 9 parts, 11 parts, red peony can be 13 parts, 14 parts, 16 parts , Bai Shao can be 14, 16, 17, Danpi can be 13, 17, Angelica can be 19, 21, Bupleurum can be 9, 11, Atractylodes can be 13, 17 9 and 11 parts of mint, 14 and 16 parts of safflower, and 13 and 17 parts of green calyx plum.
桂枝,辛、甘,温。归心、肺、膀胱经。具有温通经脉,助阳化气,平冲降气的功效。桂枝能温中散寒,宣导活血药物,以增强化瘀之效,对于妇女寒凝血滞,月经不调,经闭痛经,产后腹痛具有较好的疗效。Guizhi, pungent, sweet, warm. Return to the heart, lung and bladder meridians. It has the effect of warming the meridians, helping the yang to transform the qi, and calming the qi and lowering the qi. Guizhi can warm the middle and dispel cold, promote blood-activating drugs, and enhance the effect of removing blood stasis.
茯苓,甘、淡,平。归心、肺、脾、肾经。具有利水渗湿,健脾宁心的功效。茯苓药性平和,利水而不伤正气,与桂枝和白术配伍,药效更加。Poria, sweet, light, flat. Return to the heart, lung, spleen and kidney meridians. It has the effect of invigorating the spleen and calming the heart. Poria cocos has a mild medicinal property, benefits water without harming righteousness, and is compatible with Guizhi and Atractylodes for better medicinal effect.
桃仁,苦、甘,平。归心、肝、大肠经。具有活血祛瘀,润肠通便的功效。桃仁有舒张血管的作用,促进血液循环,促进机体排毒养颜。Peach kernel, bitter, sweet, flat. Return to the heart, liver and large intestine meridians. It has the effect of promoting blood circulation and removing blood stasis, moistening intestines and laxative. Peach kernels can dilate blood vessels, promote blood circulation, and promote detoxification of the body.
赤芍,苦,微寒。归肝经。具有清热凉血,散瘀止痛的功效。丹皮,又名牡丹皮,苦、辛、微寒,归心、肝、肾经。具有清热凉血,活血化瘀的功效。赤芍与丹皮共同作用,清血散瘀作用更佳。Red peony, bitter, slightly cold. Return to the liver meridian. It has the effect of clearing heat and cooling blood, dissipating blood stasis and relieving pain. Danpi, also known as Cortex Moutan, is bitter, acrid, slightly cold, and returns to the heart, liver and kidney meridians. It has the effect of clearing heat and cooling blood, promoting blood circulation and removing blood stasis. Red peony and Danpi work together to clear blood and dissipate blood stasis.
白芍,苦、酸,微寒。归肝、脾经。具有养血调经,敛阴止汗,平抑肝阳的功效。白芍具有明显的护肝作用和较好的增强耐缺氧和抗氧化、抗疲劳的作用,可提高人体免疫力。Paeonia lactiflora, bitter, sour, slightly cold. Return to the liver and spleen meridians. It has the functions of nourishing blood and regulating menstruation, astringing yin and stopping sweating, and calming down liver yang. Paeonia lactiflora has obvious liver-protecting effects and better enhancement of hypoxia tolerance, anti-oxidation, and anti-fatigue effects, which can improve human immunity.
当归,甘、辛,温。归肝、心、脾经。具有补血活血,调经止痛,润肠通便的功效。可用于心肝血虚,症见月经不调,与白芍、白术共用,具有更好的效果。白术,苦、甘,温。归脾、胃经。具有健脾益气,燥湿利水的功效。保护肝脏,增强机体免疫力。Angelica, sweet, pungent, warm. Returns liver, heart and spleen meridians. It has the functions of nourishing blood and promoting blood circulation, regulating menstruation and relieving pain, and moistening the bowels. It can be used for deficiency of heart, liver and blood, and irregular menstruation. Atractylodes, bitter, sweet, warm. Return to the spleen and stomach meridians. It has the effect of invigorating the spleen and nourishing qi, drying dampness and diuretic water. Protect liver and enhance immunity.
柴胡,辛、苦,微寒。归肝、胆、肺经。具有疏散退热,疏肝解郁的功效。《滇南本草》记载柴胡“行肝经逆结之气,止左胁肝气痉痛,治妇人血热烧经,能调月经。”《药品化义》则曰:“味微苦,主疏肝。”柴胡能条达肝气而疏肝解郁,可用来治疗郁症,经水不调,热入血室等症。Bupleurum, acrid, bitter, slightly cold. Returns liver, gallbladder, lung meridian. It has the effect of dispersing fever, soothing the liver and relieving depression. "Southern Yunnan Materia Medica" records that Bupleurum "introduces the qi of the liver meridian against the knot, stops the spasm of liver qi in the left flank, treats women's blood heat and burns the meridian, and can regulate menstruation." "Drug Huayi" said: "The taste is slightly bitter, Mainly soothes the liver." Bupleurum can regulate liver qi and relieve stagnation, which can be used to treat stagnation, irregular menstrual water, and heat entering the blood chamber.
甘草,甘,平。归心、肺、脾、胃经。具有补脾益气,清热解毒的功效,有助于机体新陈代谢,排出毒素。甘草还具有调和诸药的功效。Licorice, sweet, flat. Return to the heart, lung, spleen and stomach meridians. It has the functions of invigorating the spleen and replenishing qi, clearing away heat and detoxifying, helping the body to metabolize and expel toxins. Licorice also has the effect of reconciling various medicines.
薄荷,辛,凉。归肺、肝经。具有疏散风热,清理头目,疏肝行气的功效。玫瑰花,苦,寒。归肺、大肠经。具有清热解毒,理气和血、排毒养颜、舒肝解郁的功效。Mint, spicy, cool. Returns the lung and liver meridians. It has the effect of dispersing wind-heat, clearing the head, and soothe liver and qi. Rose, bitter, cold. Returns the lung and large intestine meridians. It has the functions of clearing away heat and detoxifying, regulating qi and blood, detoxifying and nourishing the face, soothing the liver and relieving depression.
红花,辛,温。归心、肝经。具有活血痛经,散瘀止痛的功效。对于痛经、经闭,产后血晕,瘀滞腹痛,胸痹心痛,血积具有较好的疗效。Safflower, pungent, warm. Heart, liver meridian. It has the effect of promoting blood circulation for dysmenorrhea, dispersing blood stasis and relieving pain. It has good curative effect on dysmenorrhea, amenorrhea, postpartum haemorrhage, abdominal pain due to stasis, chest pain, and blood accumulation.
绿萼梅,酸、涩,平。归肝、胃、肺经。具有平肝和胃、调畅气机的功效。绿萼梅行气入肝胃,能疏肝解郁,醒脾,理气和中。Green calyx plum, sour, astringent, flat. Returns liver, stomach, lung meridian. It has the effect of calming the liver and stomach and regulating Qi. Green calyx plum transports qi into the liver and stomach, soothes the liver and relieves depression, refreshes the spleen, regulates qi and neutralizes the middle.
桂枝、茯苓、桃仁、白芍、赤芍、当归、白术、柴胡、薄荷、红花及绿萼梅相配伍,具有协同增效的作用,疏肝健脾、解郁淡斑、活血化瘀,甘草调和诸药、辅助清热解毒。该组方促进体内新陈代谢,改善血液循环,清除体内过多的自由基,提高抗氧化性,从而起到抑制络氨酸酶活性,减少黑色素的形成,从而淡化或消退黄褐斑,改善皮肤;同时,对于烦躁抑郁,眩晕耳鸣,经前乳房胀痛,腹胀痛,月经量少等症状以及妇科肿瘤或囊肿均具有一定治疗作用。Cinnamon twig, Poria, peach kernel, white peony root, red peony root, angelica, Atractylodes, Bupleurum, mint, safflower and green calyx plum are compatible, with synergistic effect, soothing liver and spleen, relieving depression and reducing spots, promoting blood circulation Blood stasis, licorice reconciles various medicines, assists in clearing away heat and detoxifying. The formula promotes metabolism in the body, improves blood circulation, removes excess free radicals in the body, and improves antioxidant properties, thereby inhibiting the activity of tyrosinase and reducing the formation of melanin, thereby diluting or eliminating chloasma and improving the skin; At the same time, it has a certain therapeutic effect on symptoms such as irritability and depression, dizziness and tinnitus, breast tenderness before menstruation, abdominal distention pain, light menstrual flow, and gynecological tumors or cysts.
进一步地,在本发明较优的实施例中,按重量份数计,原料为桂枝10份,茯苓15份,桃仁10份,赤芍15份,白芍15份,丹皮15份,当归20份,柴胡10份,白术15份,甘草5份,薄荷10份,玫瑰花20份,红花12份,绿萼梅2份时,药效更加。本发明提供的中药还包括选自粘结剂、崩解剂、润滑剂中的至少一种的辅料。通过添加辅料,将中药制成不同的剂型。Further, in a preferred embodiment of the present invention, in parts by weight, the raw materials are 10 parts of cinnamon sticks, 15 parts of Poria cocos, 10 parts of peach kernels, 15 parts of red peony root, 15 parts of white peony root, 15 parts of paeonol, 15 parts of Chinese angelica 20 parts, Bupleurum 10 parts, Atractylodes 15 parts, Licorice 5 parts, Mint 10 parts, Rose 20 parts, Safflower 12 parts, Green calyx plum 2 parts, the effect is even more. The traditional Chinese medicine provided by the present invention also includes at least one auxiliary material selected from the group consisting of a binder, a disintegrant and a lubricant. By adding excipients, traditional Chinese medicines are made into different dosage forms.
本发明还提供了一种用于治疗黄褐斑的中药组合物的制备方法,包括:The present invention also provides a preparation method of a traditional Chinese medicine composition for treating chloasma, comprising:
按比例称取原料,洗净干燥后粉碎,混合得药粉。为了增强人体对药物的吸收,较优的,将原料在40~60℃的条件下干燥4~6小时,采用超微粉碎技术将原料粉碎至800目以上。The raw materials are weighed in proportion, washed and dried, pulverized, and mixed to obtain medicinal powder. In order to enhance the absorption of the drug by the human body, preferably, the raw materials are dried under the condition of 40-60°C for 4-6 hours, and the raw materials are pulverized to more than 800 meshes by the ultrafine pulverization technology.
将药粉与辅料混合,按照需要制成不同的剂型。在本发明的实施例中,为了方便患者携带和服用,将药粉与糊精混合,压制后得片剂。且片剂可以提高患者的依从性,更好的保证临床疗效。经干燥处理、检验包装,得到成品。较优的,为了增强片剂的药效,辅料的质量为原料质量的1~5%。Mix the powder with the excipients and make different dosage forms as needed. In the embodiment of the present invention, in order to be convenient for patients to carry and take, the medicinal powder is mixed with dextrin and compressed to obtain a tablet. And the tablet can improve patient compliance and better ensure clinical efficacy. After drying, inspection and packaging, the finished product is obtained. Preferably, in order to enhance the efficacy of the tablet, the quality of the auxiliary materials is 1-5% of the quality of the raw materials.
该用于治疗黄褐斑的中药组合物的制备方法,采用直接将药材打粉的方式制成药剂,使得药材中的所有成分均能入药,药材利用率高达99%以上,同该方法的工艺简单,所制得药剂的药效显著。The preparation method of the traditional Chinese medicine composition for treating chloasma adopts the method of directly powdering the medicinal materials to prepare the medicine, so that all the components in the medicinal materials can be used as medicine, the utilization rate of the medicinal materials is as high as 99%, and the process of the method is simple. , the prepared medicament has remarkable efficacy.
作为另一种实现方式,可以将粉碎的药粉用醇溶液浸提,提取药粉中的有效成分。具体的,采用体积分数为50%~60%的乙醇水溶液于60~80℃回流浸提1~3次,每次浸提6~8小时。将多次浸提液混合后浓缩干燥。将干燥后的产物与辅料混合,根据需要制成不同的剂型。该制备方法对原料进行处理,提取有效成分,进一步增强人体对药物的吸收,见效快。As another implementation manner, the pulverized medicinal powder can be leached with an alcohol solution to extract the active ingredients in the medicinal powder. Specifically, the ethanol aqueous solution with a volume fraction of 50% to 60% is used for reflux extraction at 60 to 80° C. for 1 to 3 times, and each extraction is performed for 6 to 8 hours. The multiple extracts were mixed and concentrated to dryness. The dried product is mixed with excipients to prepare different dosage forms as required. The preparation method processes the raw materials, extracts the effective components, further enhances the absorption of the medicine by the human body, and has quick effects.
以下结合实施例对本发明的特征和性能作进一步的详细描述。The features and performances of the present invention will be further described in detail below in conjunction with the embodiments.
实施例1Example 1
本实施例提供了一种用于治疗黄褐斑的中药组合物,通过以下制备方法制得:The present embodiment provides a traditional Chinese medicine composition for the treatment of chloasma, obtained by the following preparation method:
按重量份数计,称取桂枝5份,茯苓10份,桃仁5份,赤芍10份,白芍10份,丹皮10份,当归15份,柴胡5份,白术10份,甘草2份,薄荷5份,玫瑰花15份,红花10份,绿萼梅10份。In parts by weight, weigh 5 parts of cinnamon stick, 10 parts of Poria, 5 parts of peach kernel, 10 parts of red peony root, 10 parts of white peony root, 10 parts of paeonol, 15 parts of angelica, 5 parts of Bupleurum, 10 parts of Atractylodes, licorice 2 parts, 5 parts mint, 15 parts rose flower, 10 parts safflower, 10 parts green calyx plum.
将原料在40℃的条件下干燥4小时,采用超微粉碎技术将原料粉碎至800目,将质量为原料1%的糊精与药粉混合均匀制成片剂,经干燥处理、检验包装,得到成品。The raw materials are dried under the condition of 40 ° C for 4 hours, the raw materials are pulverized to 800 meshes by the ultra-fine pulverization technology, and the dextrin with a mass of 1% of the raw materials is mixed with the medicinal powder to make tablets. After drying treatment, inspection and packaging, the obtained finished product.
实施例2Example 2
本实施例提供了一种用于治疗黄褐斑的中药组合物,通过以下制备方法制得:The present embodiment provides a traditional Chinese medicine composition for the treatment of chloasma, obtained by the following preparation method:
按重量份数计,称取桂枝15份,茯苓20份,桃仁15份,赤芍20份,白芍20份,丹皮20份,当归25份,柴胡15份,白术20份,甘草8份,薄荷15份,玫瑰花25份,红花20份,绿萼梅20份。In parts by weight, weigh 15 parts of cassia twig, 20 parts of Poria, 15 parts of peach kernel, 20 parts of red peony root, 20 parts of white peony root, 20 parts of paeonol, 25 parts of angelica, 15 parts of Bupleurum, 20 parts of Atractylodes, licorice 8 servings, mint 15, rose 25, safflower 20, green calyx plum 20.
将原料在60℃的条件下干燥6小时,采用超微粉碎技术将原料粉碎至1000目,将质量为原料5%的糊精与药粉混合均匀制成片剂,经干燥处理、检验包装,得到成品。The raw materials are dried under the condition of 60 ° C for 6 hours, the raw materials are pulverized to 1000 mesh by the ultra-fine pulverization technology, the dextrin whose mass is 5% of the raw materials and the medicinal powder are mixed uniformly to make tablets, and after drying treatment, inspection and packaging, the obtained finished product.
实施例3Example 3
本实施例提供了一种用于治疗黄褐斑的中药组合物,通过以下制备方法制得:The present embodiment provides a traditional Chinese medicine composition for the treatment of chloasma, obtained by the following preparation method:
按重量份数计,称取桂枝8份,茯苓18份,桃仁8份,赤芍18份,白芍12份,丹皮18份,当归18份,柴胡2份,白术12份,甘草2份,薄荷12份,玫瑰花22份,红花18份,绿萼梅12份。In parts by weight, weigh 8 parts of cinnamon sticks, 18 parts of Poria cocos, 8 parts of peach kernels, 18 parts of red peony root, 12 parts of white peony root, 18 parts of paeonol, 18 parts of angelica, 2 parts of Bupleurum, 12 parts of Atractylodes, licorice 2 parts, 12 parts mint, 22 parts rose flower, 18 parts safflower, 12 parts green calyx plum.
将原料在50℃的条件下干燥5小时,采用超微粉碎技术将原料粉碎至900目。将粉碎的药粉采用体积分数为60%的乙醇水溶液于80℃回流浸提1次,每次浸提6小时。将多次浸提液混合后浓缩干燥。将干燥后的产物与质量为原料4%的糊精混合均匀制成片剂,经干燥处理、检验包装,得到成品。The raw materials were dried at 50° C. for 5 hours, and the raw materials were pulverized to 900 meshes by ultra-fine pulverization technology. The pulverized medicinal powder was leached once with 60% ethanol aqueous solution at 80°C under reflux for 6 hours each time. The multiple extracts were mixed and concentrated to dryness. The dried product is uniformly mixed with dextrin with a mass of 4% of the raw material to prepare a tablet, and the finished product is obtained after drying treatment, inspection and packaging.
实施例4Example 4
本实施例提供了一种用于治疗黄褐斑的中药组合物,通过以下制备方法制得:The present embodiment provides a traditional Chinese medicine composition for the treatment of chloasma, obtained by the following preparation method:
按重量份数计,称取桂枝12份,茯苓12份,桃仁12份,赤芍12份,白芍12份,丹皮12份,当归18份,柴胡12份,白术12份,甘草8份,薄荷12份,玫瑰花18份,红花12份,绿萼梅12份。In parts by weight, weigh 12 parts of cinnamon sticks, 12 parts of Poria, 12 parts of peach kernels, 12 parts of red peony root, 12 parts of white peony root, 12 parts of paeonol, 18 parts of angelica, 12 parts of Bupleurum, 12 parts of Atractylodes, licorice 8 parts, 12 parts mint, 18 parts rose, 12 parts safflower, 12 parts green calyx plum.
将原料在55℃的条件下干燥5小时,采用超微粉碎技术将原料粉碎至850目。将粉碎的药粉采用体积分数为50%~60%的乙醇水溶液于65℃回流浸提2次,每次浸提7小时。将多次浸提液混合后浓缩干燥。将干燥后的产物与质量为原料2%的糊精混合均匀制成片剂,经干燥处理、检验包装,得到成品。The raw materials were dried at 55°C for 5 hours, and the raw materials were pulverized to 850 meshes by ultra-fine pulverization technology. The pulverized medicinal powder is extracted twice by refluxing the 50%-60% ethanol aqueous solution at 65° C. for 7 hours each time. The multiple extracts were mixed and concentrated to dryness. The dried product is uniformly mixed with dextrin whose mass is 2% of the raw material to make tablets, and the finished product is obtained after drying treatment, inspection and packaging.
实施例5Example 5
本实施例提供了一种用于治疗黄褐斑的中药组合物,通过以下制备方法制得:The present embodiment provides a traditional Chinese medicine composition for the treatment of chloasma, obtained by the following preparation method:
按重量份数计,称取桂枝10份,茯苓15份,桃仁10份,赤芍15份,白芍15份,丹皮15份,当归20份,柴胡10份,白术15份,甘草5份,薄荷10份,玫瑰花20份,红花12份,绿萼梅12份。In parts by weight, weigh 10 parts of cinnamon sticks, 15 parts of Poria cocos, 10 parts of peach kernels, 15 parts of red peony root, 15 parts of white peony root, 15 parts of paeonol, 20 parts of angelica, 10 parts of Bupleurum, 15 parts of Atractylodes, licorice 5 parts, 10 parts mint, 20 parts rose flower, 12 parts safflower, 12 parts green calyx plum.
将原料在50℃的条件下干燥5小时,采用超微粉碎技术将原料粉碎至900目,将质量为原料3%的糊精与药粉混合均匀制成片剂,经干燥处理、检验包装,得到成品。The raw materials are dried under the condition of 50 ° C for 5 hours, and the raw materials are pulverized to 900 mesh by the ultra-fine pulverization technology. finished product.
对比例1Comparative Example 1
本对比例提供了一种用于治疗黄褐斑的中药组合物,通过以下制备方法制得:The present comparative example provides a traditional Chinese medicine composition for the treatment of chloasma, obtained by the following preparation method:
按重量份数计,称取桂枝10份,茯苓15份,桃仁10份,赤芍15份,白芍15份,丹皮15份,当归20份,柴胡10份,白术15份,甘草5份,薄荷10份,玫瑰花20份,红花12份,绿萼梅12份。In parts by weight, weigh 10 parts of cinnamon sticks, 15 parts of Poria cocos, 10 parts of peach kernels, 15 parts of red peony root, 15 parts of white peony root, 15 parts of paeonol, 20 parts of angelica, 10 parts of Bupleurum, 15 parts of Atractylodes, licorice 5 parts, 10 parts mint, 20 parts rose flower, 12 parts safflower, 12 parts green calyx plum.
将原料用冷水浸泡30min;Soak the raw materials in cold water for 30min;
浸泡后,用武火煮沸,再用文火煎煮35分钟,过滤得第一滤液和药渣;After soaking, boil with strong fire, then decocted with slow fire for 35 minutes, and filter to obtain the first filtrate and medicinal residue;
将药渣加水,用武火煮沸后再用文火煎煮25分钟,过滤得第二滤液;合并第一滤液、第二滤液。The medicinal residues are added with water, boiled with high heat and then decocted with slow heat for 25 minutes, and filtered to obtain the second filtrate; the first filtrate and the second filtrate were combined.
对比例2Comparative Example 2
本对比例提供了一种用于治疗黄褐斑的中药组合物,通过以下制备方法制得:The present comparative example provides a traditional Chinese medicine composition for the treatment of chloasma, obtained by the following preparation method:
按重量份数计,称取桂枝10份,茯苓15份,当归20份,白术15份。In parts by weight, weigh 10 parts of cinnamon sticks, 15 parts of Poria, 20 parts of Angelica sinensis, and 15 parts of Atractylodes Rhizoma.
将原料在50℃的条件下干燥5小时,采用超微粉碎技术将原料粉碎至900目,将质量为原料3%的糊精与药粉混合均匀制成片剂,经干燥处理、检验包装,得到成品。The raw materials are dried under the condition of 50 ° C for 5 hours, and the raw materials are pulverized to 900 mesh by the ultra-fine pulverization technology. finished product.
试验例临床试验test case clinical trial
1.病例入选1. Case selection
全部病例来源于某医院诊断患有黄褐斑的患者,入选210例患者,均为女性,年龄18~60岁,无感染、对本药不过敏。将其随机分为7组,每组30人,各组患者的性别、病期等一般资料比较,差异无统计学意义(p>0.05)。All the cases were from patients diagnosed with chloasma in a hospital. 210 patients were selected, all of them were female, aged 18-60 years old, without infection and not allergic to this drug. They were randomly divided into 7 groups with 30 patients in each group. There was no significant difference in the general data such as gender and disease stage among the groups (p>0.05).
2.治疗方法2. Treatment
1~7组的患者分别口服实施例1~5、对比例1、2提供的中药。每日口服3次,每次6~8片,一个月一个疗程,使用4个疗程。The patients in groups 1 to 7 took the traditional Chinese medicines provided in Examples 1 to 5 and Comparative Examples 1 and 2 orally respectively. Oral 3 times a day, 6 to 8 tablets each time, one course of treatment per month, 4 courses of treatment.
3.疗效判定标准3. Efficacy criteria
显效:肉眼视色斑面积消退大于60%,颜色明显变淡。Marked effect: The area of the stains is reduced by more than 60%, and the color is obviously lighter.
好转:肉眼视色斑面积消退大于30%,颜色变淡。Improvement: The area of pigmentation spots disappeared by more than 30%, and the color became lighter.
无效:肉眼视色斑面积消退小于30%,颜色变化不明显。Invalid: The subsided area of the color spot is less than 30%, and the color change is not obvious.
4.结果及分析4. Results and Analysis
表1疗效结果表Table 1 Efficacy results table
由表1可知,实施例1~5和对比例1提供的用于治疗黄褐斑的中药组合物的总有效率均较高,说明其均对黄褐斑有较好的治疗效果。在增加疗程后,总有效率更高。对比例2的中药配方较实施例1~5和对比例1的配方少几味中药,药效降低,效果较差。其中实施例5和对比例1提供的用于治疗黄褐斑的中药组合物的效果较好,说明组方合理,制备方法更加科学。实施例5提供的为片剂,相比于对比例1提供的汤剂,更加方便携带和服用。It can be seen from Table 1 that the total effective rates of the traditional Chinese medicine compositions for the treatment of chloasma provided in Examples 1 to 5 and Comparative Example 1 are all high, indicating that they all have a good therapeutic effect on chloasma. After increasing the course of treatment, the total effective rate was higher. Compared with the formulations of Examples 1-5 and Comparative Example 1, the traditional Chinese medicine formula of Comparative Example 2 has fewer traditional Chinese medicines, and the efficacy is reduced and the effect is poor. Among them, the effect of the traditional Chinese medicine composition for treating chloasma provided in Example 5 and Comparative Example 1 is better, indicating that the formulation is reasonable and the preparation method is more scientific. The tablet provided in Example 5 is more convenient to carry and take than the decoction provided in Comparative Example 1.
试验例典型病例Test case typical case
樊某,女,38岁,农民,双颧部出对称性黄褐斑3年,平素操持农活及家务繁琐,性格急躁,常觉口苦咽干,月经量少伴血块。给予中药汤剂:桂枝10g,茯苓15g,桃仁10g,赤芍15g,白芍15g,丹皮15g,当归20g,柴胡10g,白术15g,甘草5g,薄荷10g,玫瑰花20g,红花15g,绿萼梅15g,每日1剂,并嘱其保湿防晒。服10天后黄褐斑颜色明显变淡,自觉性情较前平和,口苦咽干基本不觉。按原方再服10剂,斑色基本不显,适逢月经来潮,量较前明显增多,未见血块,自觉身体舒畅。Fan Mou, female, 38 years old, farmer, has symmetrical chloasma on both cheeks for 3 years, usually manages farm work and tedious housework, has a irritable personality, often feels bitterness in the mouth and dry throat, and has light menstrual flow and blood clots. Give traditional Chinese medicine decoction: 10g cassia twig, 15g Poria, 10g peach kernel, 15g red peony, 15g white peony, 15g paeonol, 20g angelica, 10g Bupleurum, 15g Atractylodes, 5g licorice, 10g mint, 20g rose, 15g safflower , Green calyx plum 15g, 1 dose a day, and ask it to moisturize and sunscreen. After taking it for 10 days, the color of the chloasma was obviously lighter, the conscious temperament was calmer than before, and the mouth was bitter and dry and the throat was almost unnoticeable. Taking another 10 doses according to the original prescription, the spots and color are basically not obvious. It coincides with the menstrual cramps, and the amount is significantly increased compared with the previous one.
综上所述,本发明提供的用于治疗黄褐斑的中药组合物具有“疏肝健脾、解郁淡斑、活血化瘀”的作用,能够调节机体免疫力,改善血液循环,清除自由基,提高抗氧化性,从而起到抑制络氨酸酶活性,减少黑色素的形成,淡化或消退黄褐斑,改善皮肤外观,提高生活质量。同时该组方对于烦躁抑郁,眩晕耳鸣,经前乳房胀痛,腹胀痛,月经量少等症状以及妇科肿瘤或囊肿均具有一定治疗作用。该组方选用天然中草药为原料,安全性能高,无毒副作用。To sum up, the traditional Chinese medicine composition for the treatment of chloasma provided by the present invention has the functions of "soothing the liver and strengthening the spleen, relieving depression and lightening spots, promoting blood circulation and removing blood stasis", which can regulate the immunity of the body, improve blood circulation, and remove free radicals. It can inhibit the activity of tyrosinase, reduce the formation of melanin, lighten or subside melasma, improve the appearance of the skin, and improve the quality of life. At the same time, the prescription has a certain therapeutic effect on irritability and depression, dizziness and tinnitus, breast tenderness before menstruation, abdominal distention pain, light menstrual flow and other symptoms, as well as gynecological tumors or cysts. The prescription adopts natural Chinese herbal medicine as raw material, and has high safety performance and no toxic and side effects.
以上所描述的实施例是本发明一部分实施例,而不是全部的实施例。本发明的实施例的详细描述并非旨在限制要求保护的本发明的范围,而是仅仅表示本发明的选定实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The above-described embodiments are some, but not all, embodiments of the present invention. The detailed descriptions of the embodiments of the invention are not intended to limit the scope of the invention as claimed, but are merely representative of selected embodiments of the invention. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative efforts shall fall within the protection scope of the present invention.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711087678.8A CN107714798B (en) | 2017-11-07 | 2017-11-07 | A kind of traditional Chinese medicine composition for treating chloasma and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711087678.8A CN107714798B (en) | 2017-11-07 | 2017-11-07 | A kind of traditional Chinese medicine composition for treating chloasma and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107714798A CN107714798A (en) | 2018-02-23 |
| CN107714798B true CN107714798B (en) | 2020-07-24 |
Family
ID=61221764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711087678.8A Active CN107714798B (en) | 2017-11-07 | 2017-11-07 | A kind of traditional Chinese medicine composition for treating chloasma and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107714798B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108273025A (en) * | 2018-03-27 | 2018-07-13 | 贵州康珠药业有限公司 | It is a kind of to be used to improve plaster of depression and preparation method thereof |
| CN113908191A (en) * | 2021-10-09 | 2022-01-11 | 杨业 | Composition for treating chloasma and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1799607A (en) * | 2004-12-31 | 2006-07-12 | 张恒钊 | Chinese medicinal compound prescription for treating chloasma |
| CN103212021A (en) * | 2013-03-26 | 2013-07-24 | 孙胜波 | Traditional Chinese medicine composition used for treating chloasma |
-
2017
- 2017-11-07 CN CN201711087678.8A patent/CN107714798B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN107714798A (en) | 2018-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113827687B (en) | A kind of traditional Chinese medicine preparation for treating thyroid nodules and preparation method thereof | |
| CN103520572A (en) | Traditional Chinese composition used for treating atopic dermatitis as well as preparation method of composition | |
| CN106728457A (en) | A kind of Traditional Chinese medicine acne treatment mask | |
| CN104383296A (en) | Traditional Chinese medicine composition for treating xerophthalmia and preparation method of traditional Chinese medicine composition for treating xerophthalmia | |
| CN103316146A (en) | Traditional Chinese medicinal preparation for anesthesia | |
| CN107714798B (en) | A kind of traditional Chinese medicine composition for treating chloasma and preparation method thereof | |
| CN107737288B (en) | Traditional Chinese medicine composition for treating allergic asthma and preparation method thereof | |
| CN103520571B (en) | Traditional Chinese medicine for treating qi stagnation and blood stasis syndrome type abdominal mass diseases | |
| CN103611021B (en) | Be used for the treatment of medicine of Vesica sus domestica inflammation and preparation method thereof | |
| CN103638388B (en) | A kind of Chinese medicine composition, preparation and preparation method thereof for the treatment of chloasma | |
| CN107812091B (en) | Traditional Chinese medicine preparation for treating phlebitis caused by chemotherapeutic drugs and preparation method thereof | |
| CN112675264B (en) | Composition for treating psoriasis, preparation method and application thereof | |
| CN112870286B (en) | Traditional Chinese medicine composition for treating atopic dermatitis, preparation method and application thereof | |
| CN104667045B (en) | Treat the drug of refractory acne | |
| CN103656050B (en) | Traditional Chinese herb medicine for the treatment of cyclomastopathy and preparation method thereof | |
| CN103520644B (en) | Traditional Chinese medicine composition used for treating phlegm stagnation type hyperlipidaemia and preparation method of composition | |
| CN107617081B (en) | Traditional Chinese medicine composition for treating alopecia and preparation method thereof | |
| CN104491718A (en) | Medicine for treating liver-depression and phlegm-stasis type mammary gland hyperplasia and preparation method | |
| CN104940524B (en) | It is a kind of to be used to treat drug of leucoderma and preparation method thereof | |
| CN117224631B (en) | Traditional Chinese medicine composition for adolescent acne diseases and preparation method and application thereof | |
| CN115154550B (en) | A kind of external Chinese medicinal composition for treating ulcerative lymph node tuberculosis | |
| CN104800670B (en) | A kind of traditional Chinese medicine composition for removing freckles and its preparation method and application | |
| CN104645138B (en) | A kind of medicine for treating refractory acne | |
| CN117815349A (en) | Traditional Chinese medicine composition for treating meningioma and preparation method thereof | |
| CN108888660A (en) | A kind of low irritant drug and preparation method thereof for treating acne or acne rosacea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |